文献速递中毒与环境急症

香港蛇抗毒血清安全性回顾:2008至2015年191例分析

Safety profile of snake antivenom (use) in Hong Kong - a review of 191 cases from 2008 to 2015.
PubMed 文献 · Clin Toxicol (Phila) · 2017-06-28
一句话结论香港常用蛇抗毒血清即速过敏反应发生率低(泰国绿蝮蛇抗毒血清4.7%、中国蝮蛇抗毒血清1.4%),多数患者可在急诊观察病房或普通病房安全处理。

该研究回顾香港中毒信息中心数据库2008至2015年所有接受蛇抗毒血清的患者共191例,提取人口学、蛇种、抗毒血清种类、治疗地点、预处理、ICU入住原因及早期和晚期反应。多数(93%)使用泰国绿蝮蛇抗毒血清或中国蝮蛇抗毒血清,二者即速过敏反应发生率分别为4.7%和1.4%。69%患者在急诊观察病房或普通病房处理,59例入住ICU者中90%仅为抗毒血清输注期间密切监测。作者结论认为香港常用抗毒血清即速过敏反应发生率低,血清病不常见且表现轻微。

要点

  • 191例接受蛇抗毒血清患者中,泰国绿蝮蛇抗毒血清即速过敏反应发生率4.7%,中国蝮蛇抗毒血清1.4%。
  • 69%患者在急诊观察病房或普通病房处理,未发生抗毒血清给药导致的显著病残。
  • 59例入住ICU患者中90%仅为抗毒血清输注期间密切监测而收入ICU。
  • 8例(5.6%)出现提示轻度血清病的特征。

适用人群与场景

  • 2008至2015年香港中毒信息中心数据库中所有接受蛇抗毒血清的患者,共191例。

研究设计与关键结果

  • 回顾性分析香港中毒信息中心数据库2008至2015年191例接受蛇抗毒血清患者。
  • 93%患者使用泰国绿蝮蛇抗毒血清或中国蝮蛇抗毒血清。
  • 泰国绿蝮蛇抗毒血清即速过敏反应发生率4.7%,中国蝮蛇抗毒血清即速过敏反应发生率1.4%。
  • 69%患者在急诊观察病房或普通病房处理;59例入住ICU,其中90%为抗毒血清输注期间密切监测。
  • 无抗毒血清给药导致的显著病残病例;8例(5.6%)出现提示轻度血清病的特征。

证据类型、等级与局限

  • 证据类型:回顾性数据库综述(香港中毒信息中心数据库)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论认为香港常用蛇抗毒血清即速过敏反应发生率低,多数患者可在急诊观察病房或普通病房安全处理。
  • 血清病似乎不常见,可能的病例表现为轻度特征。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: The mainstay of treatment for significant envenoming from snakebites is antivenom. However, there is insufficient data regarding the safety of antivenom used in Hong Kong. We describe the incidence of hypersensitivity reactions from antivenom use and review the frequency and reasons for intensive care unit (ICU) admission.

METHODS: The Hong Kong Poisons Information Centre database was reviewed. All patients given snake antivenom between 2008 and 2015 were included. Patient demographics, species of snake involved, details of antivenom used, treatment location, use of pre-treatment, reasons for ICU admission (where applicable) and details of early and late antivenom reactions were extracted.

RESULTS: There were 191 patients who received snake antivenom. Most (93%) were treated with either the green pit viper antivenom from Thailand or the Agkistrodon halys antivenom from China. The incidences of early hypersensitivity reactions to green pit viper antivenom and Agkistrodon Halys antivenom were 4.7% and 1.4%, respectively. Most patients (69%) were managed in the ED observation ward or general ward. There were 59 patients managed in ICU, most (90%) of whom were admitted for close monitoring during antivenom administration. There were no cases of significant morbidity from antivenom administration. Eight patients (5.6%) had features suggestive of mild serum sickness.

CONCLUSIONS: The incidence of immediate hypersensitivity reaction to antivenom commonly used in Hong Kong is low. Majority of patients were managed safely in the emergency department observation ward or general ward. Serum sickness appears to be uncommon and possible cases presented with mild features.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Mong R, Ng VCH, Tse ML, et al. Safety profile of snake antivenom (use) in Hong Kong - a review of 191 cases from 2008 to 2015. Clin Toxicol (Phila). 2017. PMID: 28657429. doi:10.1080/15563650.2017.1334916

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。